E
Bright Minds Biosciences Inc. DRUG
CNSX
Recommendation
Prev Close
$120.13
Volume
--
Avg Vol (90D)
1,236
Market Cap
$847.20M
Dividend & Yield
--
52-Week Range
$33.01 - $170.00
P/E (TTM)
--
EPS (TTM)
-$1.24
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Biotechs on the Brink: 2 Stocks With Huge Potential
2/14/2025 - MarketBeat
Bright Minds Biosciences (DRUG, $90.39) Stochastic Oscillator left the oversold zone on January 22, 2026
1/23/2026 - Tickeron - Stocks
Bright Minds Biosciences (DRUG, $86.04) entered Downtrend as Momentum indicator drops below 0 level on Jan 21, 2026
1/22/2026 - Tickeron - Stocks
Bright Minds Biosciences (DRUG, $83) Stochastic Oscillator left the oversold zone on January 20, 2026
1/21/2026 - Tickeron - Stocks
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives $115.40 Average Target Price from Analysts
1/19/2026 - Ticker Report
Bright Minds Biosciences (DRUG, $88.67) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 12, 2026
1/13/2026 - Tickeron - Technical Analysis
Bright Minds Biosciences (DRUG, $88.67) Aroon Indicator entered an Uptrend on January 12, 2026.
1/13/2026 - Tickeron - Technical Analysis
Wall Street Zen Downgrades Bright Minds Biosciences (NASDAQ:DRUG) to Sell
1/12/2026 - Ticker Report
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Moderate Buy" from Analysts
1/12/2026 - MarketBeat
Bright Minds Biosciences (DRUG, $86.75) Aroon Indicator entered an Uptrend on January 09, 2026.
1/10/2026 - Tickeron - Stocks
Bright Minds Biosciences (NASDAQ:DRUG) Cut to "Sell" at Wall Street Zen
1/10/2026 - MarketBeat
Bright Minds Biosciences Raises US$175 Million in Share Offering to Advance CNS Drug Pipeline
1/9/2026 - TipRanks Financial Blog
Bright Minds Biosciences (DRUG, $90.01) Aroon Indicator entered an Uptrend on January 08, 2026.
1/9/2026 - Tickeron - Technical Analysis
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
1/9/2026 - GuruFocus
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
1/9/2026 - Globe Newswire
Bright Minds Biosciences (DRUG, $95.99) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 7, 2026
1/8/2026 - Tickeron - Stocks
Bright Minds Biosciences (DRUG, $95.99) price may drop as it broke higher Bollinger Band on Jan 07, 2026
1/8/2026 - Tickeron - Stocks
Bright Minds Biosciences Prices Upsized US$175 Million Public Offering and Ends ATM Program
1/8/2026 - TipRanks Financial Blog
Bright Minds Biosciences (DRUG) Prices $175M Public Offering
1/8/2026 - GuruFocus
Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
1/8/2026 - GuruFocus
Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
1/8/2026 - Globe Newswire
Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating
1/7/2026 - SeekingAlpha
Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating
1/7/2026 - Seeking Alpha - Long Ideas
Bright Minds Biosciences Launches US$100 Million Public Offering to Fund CNS Drug Pipeline
1/7/2026 - TipRanks Financial Blog
Bright Minds Biosciences (DRUG) Launches $100 Million Public Offering
1/6/2026 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$9.76M
Net Income (TTM)
-$8.78M
Balance Sheet
Total Assets (Q)
$60.61M
Total Debt (Q)
$90.30K
Total Liabilities (Q)
$1.71M
Book Value Per Share (Q)
$7.71
Cash Flow
Cash from Operations (TTM)
-$6.21M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$61.51M
Net Change in Cash (TTM)
$55.51M
Filings
Filing Date
Tuesday, December 23, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 9 and 13 (est)
Price History
Loading...
Beta
-3.57
7-Day Total Return
-3.18%
30-Day Total Return
4.63%
60-Day Total Return
50.73%
90-Day Total Return
81.52%
Year to Date Total Return
6.12%
1-Year Total Return
164.45%
2-Year Total Return
4,936.48%
3-Year Total Return
2,240.76%
5-Year Total Return
--
52-week Low
Jun 30, 2025 - $33.01
52-week High
Jan 06, 2026 - $170.00
Valuation
Market Cap
$847.20M - Small Cap
Enterprise Value
$787.21M
Price/Sales (TTM)
--
Price/Book (Q)
15.57
Dividends and Shares
Shares Outstanding
7.23M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
brightmindsbio.com
Phone Number
647 865 8622
Address
19 Vestry Street
New York, NY 10013
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes... more